Global Health Investment Fund
Impact investorNew York Β· 1 people tracked
Investment thesis
The Global Health Investment Fund (GHIF) is a $108 million social impact fund managed under Global Health Investment Corporation, a New York-based nonprofit investor in global health innovation. The fund invested in twelve companies developing clinical diagnostics, devices, vaccines, and therapeutics targeting infectious diseases that heavily burden low- and middle-income countries, including HIV/AIDS, malaria, tuberculosis, and cholera. Its portfolio companies have commercialized more than a dozen products delivered to over 500 million people.
Team Β· 1 people
from the firm's websiteFrequently asked questions
- What sectors does Global Health Investment Fund focus on?
- Global Health Investment Fund focuses on Biotech, Healthtech, Impact & Social Good, Medical Devices.
- Where is Global Health Investment Fund located?
- Global Health Investment Fund is headquartered in New York, US.
Similar investors
Granatus Ventures is a venture capital firm that backs startups worldwide leveraging Armenia's potential as an emerging technology hub.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Nesta is a UK research and innovation foundation that designs, tests and scales solutions to major societal challenges, working across the innovation lifecycle. It operates mission-led programmes and makes impact investments, including building mission-led start-ups through its Mission Studio.
H2O creates and builds new social enterprises from scratch that supply products and services to smallholder farmers across developing agricultural value chains, aiming to combine commercial returns with long-term impact.
GO Capital is a French investment firm founded in 2003 that backs high-growth companies in digital, health, and industry-of-the-future sectors, with a focus on sustainable innovation across regional territories.